James Wightman Davidson
Affiliations: | University of Cambridge, Cambridge, England, United Kingdom |
Google:
"James Davidson"Parents
Sign in to add mentor| Eric Anderson Walker | grad student | 1942 | Cambridge | |
| ("European penetration of the South Pacific, 1779-1842") | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Szlavik Z, Csekei M, Paczal A, et al. (2020) Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor. Journal of Medicinal Chemistry |
| Szlávik Z, Ondi L, Csékei M, et al. (2019) Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity. Journal of Medicinal Chemistry |
| Maragno AL, Mistry P, Kotschy A, et al. (2019) Abstract 4482: S64315 (MIK665) is a potent and selective Mcl1 inhibitor with strong antitumor activity across a diverse range of hematologic tumor models Cancer Research. 79: 4482-4482 |
| Casara P, Davidson J, Claperon A, et al. (2018) S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth. Oncotarget. 9: 20075-20088 |
| Casara P, Davidson J, Claperon A, et al. (2018) S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth. Oncotarget. 9: 20075-20088 |
| Kotschy A, Szlavik Z, Murray J, et al. (2016) The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature |
| Geneste O, Murray J, Diguarher TL, et al. (2012) Abstract 2782: Bcl-2 selective antagonists show antitumor activity without dose limiting platelet toxicity Cancer Research. 72: 2782-2782 |